Filter your results
- 1
- 1
- 2
- 2
- 1
- 1
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
ELLIPSE Study: A Phase 1 study evaluating the tolerance of bevacizumab nasal spray in the treatment of epistaxis in hereditary hemorrhagic telangiectasia.mAbs, 2014, 6 (3), pp.793-8. ⟨10.4161/mabs.28025⟩
Journal articles
hal-00991138v1
|
||
|
Dose – response relationship of bevacizumab in hereditary hemorrhagic telangiectasiamAbs, 2015, 7 (3), pp.630 - 637. ⟨10.1080/19420862.2015.1022693⟩
Journal articles
hal-01769884v1
|